These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 8326017)

  • 1. Inhibition of Ca(2+)-dependent K+ transport and cell dehydration in sickle erythrocytes by clotrimazole and other imidazole derivatives.
    Brugnara C; de Franceschi L; Alper SL
    J Clin Invest; 1993 Jul; 92(1):520-6. PubMed ID: 8326017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral administration of clotrimazole and blockade of human erythrocyte Ca(++)-activated K+ channel: the imidazole ring is not required for inhibitory activity.
    Brugnara C; Armsby CC; Sakamoto M; Rifai N; Alper SL; Platt O
    J Pharmacol Exp Ther; 1995 Apr; 273(1):266-72. PubMed ID: 7714775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment with oral clotrimazole blocks Ca(2+)-activated K+ transport and reverses erythrocyte dehydration in transgenic SAD mice. A model for therapy of sickle cell disease.
    De Franceschi L; Saadane N; Trudel M; Alper SL; Brugnara C; Beuzard Y
    J Clin Invest; 1994 Apr; 93(4):1670-6. PubMed ID: 7512989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic strategies for prevention of sickle cell dehydration.
    Brugnara C
    Blood Cells Mol Dis; 2001; 27(1):71-80. PubMed ID: 11358364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of 1-chloro-2,4-dinitrobenzene on K+ transport in normal and sickle human red blood cells.
    Muzyamba MC; Gibson JS
    J Physiol; 2003 Mar; 547(Pt 3):903-11. PubMed ID: 12576491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The antifungal antibiotic, clotrimazole, inhibits Cl- secretion by polarized monolayers of human colonic epithelial cells.
    Rufo PA; Jiang L; Moe SJ; Brugnara C; Alper SL; Lencer WI
    J Clin Invest; 1996 Nov; 98(9):2066-75. PubMed ID: 8903326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ICA-17043, a novel Gardos channel blocker, prevents sickled red blood cell dehydration in vitro and in vivo in SAD mice.
    Stocker JW; De Franceschi L; McNaughton-Smith GA; Corrocher R; Beuzard Y; Brugnara C
    Blood; 2003 Mar; 101(6):2412-8. PubMed ID: 12433690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel inhibitors of the Gardos channel for the treatment of sickle cell disease.
    McNaughton-Smith GA; Burns JF; Stocker JW; Rigdon GC; Creech C; Arrington S; Shelton T; de Franceschi L
    J Med Chem; 2008 Feb; 51(4):976-82. PubMed ID: 18232633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of red cell dehydration: a possible new treatment for sickle cell disease.
    Mueller BU; Brugnara C
    Pediatr Pathol Mol Med; 2001; 20(1):15-25. PubMed ID: 12673842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Membrane transport of Na and K and cell dehydration in sickle erythrocytes.
    Brugnara C
    Experientia; 1993 Feb; 49(2):100-9. PubMed ID: 8440348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormal permeability pathways in human red blood cells.
    Ellory JC; Robinson HC; Browning JA; Stewart GW; Gehl KA; Gibson JS
    Blood Cells Mol Dis; 2007; 39(1):1-6. PubMed ID: 17434766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapy with oral clotrimazole induces inhibition of the Gardos channel and reduction of erythrocyte dehydration in patients with sickle cell disease.
    Brugnara C; Gee B; Armsby CC; Kurth S; Sakamoto M; Rifai N; Alper SL; Platt OS
    J Clin Invest; 1996 Mar; 97(5):1227-34. PubMed ID: 8636434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The antifungal imidazole clotrimazole and its major in vivo metabolite are potent blockers of the calcium-activated potassium channel in murine erythroleukemia cells.
    Rittenhouse AR; Vandorpe DH; Brugnara C; Alper SL
    J Membr Biol; 1997 May; 157(2):177-91. PubMed ID: 9151659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Red cell volume-related ion transport systems in hemoglobinopathies.
    Canessa M
    Hematol Oncol Clin North Am; 1991 Jun; 5(3):495-516. PubMed ID: 1650770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-acetylcysteine and clotrimazole inhibit sickle erythrocyte dehydration induced by 1-chloro-2,4-dinitrobenzene.
    Shartava A; Shah AK; Goodman SR
    Am J Hematol; 1999 Sep; 62(1):19-24. PubMed ID: 10467272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical trials of new therapeutic pharmacology for sickle cell disease].
    Brugnara C; de Franceschi L
    Sante; 2006; 16(4):263-8. PubMed ID: 17446160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dehydration response of sickle cells to sickling-induced Ca(++) permeabilization.
    Lew VL; Etzion Z; Bookchin RM
    Blood; 2002 Apr; 99(7):2578-85. PubMed ID: 11895796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The feasibility of pharmacological volume control of sickle cells is dependent on the quantization of the transport pathways. A model study.
    Bennekou P
    J Theor Biol; 1999 Jan; 196(1):129-37. PubMed ID: 9892561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythrocyte dehydration in pathophysiology and treatment of sickle cell disease.
    Brugnara C
    Curr Opin Hematol; 1995 Mar; 2(2):132-8. PubMed ID: 9371983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of abnormal hemoglobins on the membrane regulation of cell hydration.
    Clark MR; Shohet SB
    Tex Rep Biol Med; 1980-1981; 40():417-29. PubMed ID: 7034277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.